The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples